BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1684 related articles for article (PubMed ID: 22455593)

  • 1. Role of microRNAs in gynecological pathology.
    Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
    Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs and angiogenesis in endometriosis.
    Marí-Alexandre J; García-Oms J; Barceló-Molina M; Gilabert-Aguilar J; Estellés A; Braza-Boíls A; Gilabert-Estellés J
    Thromb Res; 2015 Feb; 135 Suppl 1():S38-40. PubMed ID: 25903532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA and gynecological reproductive diseases.
    Santamaria X; Taylor H
    Fertil Steril; 2014 Jun; 101(6):1545-51. PubMed ID: 24882618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in gynecological cancers: Small molecules with big implications.
    Srivastava SK; Ahmad A; Zubair H; Miree O; Singh S; Rocconi RP; Scalici J; Singh AP
    Cancer Lett; 2017 Oct; 407():123-138. PubMed ID: 28549791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microRNAs in endometriosis and associated reproductive conditions.
    Teague EM; Print CG; Hull ML
    Hum Reprod Update; 2010; 16(2):142-65. PubMed ID: 19773286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
    Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
    Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal fluid reduces angiogenesis-related microRNA expression in cell cultures of endometrial and endometriotic tissues from women with endometriosis.
    Braza-Boïls A; Gilabert-Estellés J; Ramón LA; Gilabert J; Marí-Alexandre J; Chirivella M; España F; Estellés A
    PLoS One; 2013; 8(4):e62370. PubMed ID: 23620826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview.
    Di Fiore R; Suleiman S; Pentimalli F; O'Toole SA; O'Leary JJ; Ward MP; Conlon NT; Sabol M; Ozretić P; Erson-Bensan AE; Reed N; Giordano A; Herrington CS; Calleja-Agius J
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of MicroRNAs as Potential Biomarkers in Ovarian Endometriosis.
    Gu CL; Zhang Z; Fan WS; Li LA; Ye MX; Zhang Q; Zhang NN; Li Z; Meng YG
    Reprod Sci; 2020 Sep; 27(9):1715-1723. PubMed ID: 32651898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microRNAs in endocrine cancer metastasis.
    Lima CR; Gomes CC; Santos MF
    Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells.
    Abe W; Nasu K; Nakada C; Kawano Y; Moriyama M; Narahara H
    Hum Reprod; 2013 Mar; 28(3):750-61. PubMed ID: 23293219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of microRNAs in glycolysis in gynecological tumors (Review).
    Chen Q; Shen S; Lv N; Tong J
    Int J Oncol; 2023 May; 62(5):. PubMed ID: 37052244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs as potential biomarkers in cancer: opportunities and challenges.
    Lan H; Lu H; Wang X; Jin H
    Biomed Res Int; 2015; 2015():125094. PubMed ID: 25874201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA and Metastasis.
    Ma L
    Adv Cancer Res; 2016; 132():165-207. PubMed ID: 27613133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role and Applications of Exosomes in Gynecological Cancer: A Review.
    Wang KH; Ding DC
    Cell Transplant; 2023; 32():9636897231195240. PubMed ID: 37632354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
    Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNAs related to angiogenesis in gynecological cancer.
    Rahimian N; Razavi ZS; Aslanbeigi F; Mirkhabbaz AM; Piroozmand H; Shahrzad MK; Hamblin MR; Mirzaei H
    Gynecol Oncol; 2021 Jun; 161(3):896-912. PubMed ID: 33781555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.
    Traver S; Assou S; Scalici E; Haouzi D; Al-Edani T; Belloc S; Hamamah S
    Hum Reprod Update; 2014; 20(6):905-23. PubMed ID: 24973359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of microRNA Let-7d in Female Malignancies and Diseases of the Female Reproductive Tract.
    De Santis C; Götte M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 85.